Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out


March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect TMAU

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed
Follow MeBOResearch on Twitter

Blog Archive

MEBO Metabolic Malodor Survey (international) for Dr Hazen click here
click to Read more/less

survey for ANYONE who identifies with METABOLIC MALODOR

begun : Oct20
end : no ending for now

Regular readers will know that Dr Stan Hazen et al at Cleveland Clinic are developing a TMA-blocker pill, as they proposed in a 2011 paper that TMAO is a factor in CVD. Recently Dr Hazen and colleagues contacted MEBO as they have always thought they could also help with TMAU. This survey is to give them an idea of the 'state of the community'. It is a "version 1". They may not even look (though they have access permission), but it could be useful to give them an overview of the community

MEBO had a zoom call with Dr Hazen and his team in October. Another zoom call is planned when they have time

This is a GOOGLE FORMS survey

short url for survey :

current participants : 113 (update 18dec20)

Tuesday, April 17, 2012

Alveolar breath testing in Chicago : scheduled April 21 & 22

MEBO - Menssana alveolar breath exploratory study : Chicago 21-22

Chicago testing : 21 & 22 April
If you would like to test then contact
First testing of the Alveolar breath exploratory study is scheduled to take place in Chicago 21 & 22 under the guidance of MEBO's Managing Director Mike. It is hoped testing can continue in various locations over the year with the hope that a 'trend' may appear that will take the systemic malodor community a step further than the only test currently on offer; for trimethylaminuria.

Alveolar breath is breath that has circulated systemically and is expired from the lungs. For that reason it could be a good way of spotting compounds circulating in the blood. This means it will probably be most suitable for anyone who thinks they have a body odor or halitosis that is systemically sourced (i.e. a metabolic malodor problem).

The Menssana breath capture apparatus used to collect samples can only detect compounds containing more than 3 carbons. This means it will miss a few 'prime suspects' we would be looking for that are FMO3 substrates, such as trimethylamine and dimethylsulfide. However it seems FMO3 substrates can have more than 3 carbons, so it is hoped perhaps some will be spotted (if FMO3 is an issue).

However, it must be kept in mind that this is research into a new area and it is not known what or if anything will be of any significance. Expectations are best to be kept low for the study. Each sample will be tested for 200 compounds.

Unfortunately due to no funding, any volunteers will need to pay their own sample to cover the costs. Currently this is set at $345.

It is hoped that testing can occur in various locations worldwide. Apparently training for the test and testing is relatively simple. It involves blowing into the breath apparatus for a few minutes and then the canister is sent to Menssana for testing. This will be the first testing. Provisionally, it is planned to take place in a library private room. If you would like to know more you can contact Mike at

Or use your credit card to make your donation

A EURORDIS and NORD Member Organization 


Post a Comment